“The deal will allow Bayer to tap growing demand at a time when farmers must boost food productivity to feed an estimated 10 billion people worldwide by the year 2050,” RT America’s Ashlee Banks said, adding that Bayer CEO Werner Baumann hopes that this rationale will win over skeptical investors and overcome anti-GMO backlash.
Some Bayer shareholders were critical of the bid, saying the $122 per share was too high already. Monsanto’s shares rose to $107.61 on the New York Stock Exchange on Tuesday morning, short of Bayer’s valuation.
Meanwhile, Bayer’s shares rose by 3.23 percent, reaching 87.15 Euros at the Frankfurt exchange.
The German conglomerate now has to decide whether to raise the offer, walk away, or attempt a hostile takeover.
“The danger is that you start then having discussions about how you are going to fund the higher offer, because they are already stretching the balance sheet,” Andrea Williams, fund manager at Royal London Asset Management, told Bloomberg.
If successful, the deal would eclipse the planned combination of the agricultural units of Dow Chemical and DuPont, and would also become the biggest-ever corporate buyout by a German company.
Source Article from http://feedproxy.google.com/~r/blacklistednews/hKxa/~3/pN6II8dbq98/M.html
Related posts:
Views: 0